About Verdant Life Sciences
Verdant Life Sciences is a Healthcare company based in Visakhapatnam (India) founded in 2008 by V Satyanarayana Murthy, U Amarnath, and Dharma Pracharak Ramineni. Active pharmaceutical ingredients are manufactured for the biopharma sector. It operates on a Reseller / Distribution model. Verdant Life Sciences has raised $1.43 million across 3 funding rounds from investors including Venigalla Sambasiva Rao, Pathuri Nagabhushanan and Manthena Raju. The company has 139 employees. Verdant Life Sciences was last valued at $33.41 million in April 2012. Its Indian entity Verdant Life Sciences Private Limited reported revenue of ₹89.48 Cr. Verdant Life Sciences offers products and services including Active Pharmaceutical Ingredients and Intermediates. Its focus areas include Pharmaceuticals and Active Pharmaceutical Ingredients. Its competitors include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed competitors have raised funding.
Company details
Verdant Life Sciences Is Engaged In The Production Of Active Pharmaceutical Ingredients And Intermediates. Based In India, The Company Serves Both Domestic And International Markets, Exporting To 18 Countries. Their State-of-the-art Manufacturing Facility Is Located In Visakhapatnam, Supported By Certifications Such As Who Gmp And Iso 9001:2015. Research And Development Efforts Are Directed Towards Non-infringing Apis. Products Are Supplied To Various Pharmaceutical Sectors With A Commitment To Quality.
- Headquarters Visakhapatnam, India
- Employees 139
- Founders V Satyanarayana Murthy, U Amarnath, Dharma Pracharak Ramineni
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website verdantpharma.com
- Social LinkedIn
- Legal Name Verdant Life Sciences Pvt Ltd
- Date of Incorporation 09 Jun, 2008
- Jurisdiction Andhra Pradesh, India
- Annual Revenue₹89.48 Cr
FY 2025 · +6% YoY
- Net Profit₹67.2 Lakh
FY 2025 · 1% margin
- EBITDA₹7.13 Cr
FY 2025 · 8% margin
- Total Equity Funding$1.43M (USD)
in 3 rounds
- Latest Funding Round$590.7K (USD), Angel Round
Apr 2012
- Employee Count139
Associated legal entities of Verdant Life Sciences
Verdant Life Sciences operates through Verdant Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Verdant Life Sciences Private Limited CIN U24232AP2008PTC059563 | Active | 09 Jun 2008 | Visakhapatnam, Andhra Pradesh | ₹89.5 Cr | 139 | 4 | View details |
Products & Services of Verdant Life Sciences
Verdant Life Sciences offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients and Intermediates.
Active pharmaceutical ingredients are manufactured for medicinal use.
Intermediates are produced for pharmaceutical manufacturing processes.
Funding Insights of Verdant Life Sciences
Verdant Life Sciences has successfully raised a total of $1.43M across 3 strategic funding rounds. The most recent funding activity was a Angel Round of $590.7 thousand completed in April 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.43M
- Total Rounds 3
- Last Round Angel Round — $590,699
- First Round $437,750
(Mar 2011)
- Investors Count 3
All 3 funding rounds of Verdant Life Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2012 | $590,699 | Angel Round | $33.41M | Venigalla Sambasiva Rao | – |
| Oct 2011 | $404,408 | Angel Round | $4.57M | Pathuri Nagabhushanan | – |
| Mar 2011 | $437,750 | Angel Round | $••••• | Manthena Raju | – |
| Date | Valuation | Stage |
|---|---|---|
| Apr 2012 | $33.41M | •••••••• |
| Oct 2011 | $4.57M | •••••••• |
| Mar 2011 | $••••• | •••••••• |
Full valuation and stage history of Verdant Life Sciences
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $33.41M (Apr 2012). 3 investors in total: 0 institutional and 3 angel.
Investors in Verdant Life Sciences
Verdant Life Sciences has secured backing from 3 investors, including angel investors. Prominent investors backing the company include Venigalla Sambasiva Rao, Pathuri Nagabhushanan and Manthena Raju.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
VS Venigalla Sambasiva Rao | unknown_d9c14b4026064b24b | |||
PN Pathuri Nagabhushanan | unknown_5c0b465af0e04d388 | |||
MR Manthena Raju | unknown_101fa1550aa84589a |
Investor details for Verdant Life Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Verdant Life Sciences Private Limited (Verdant Life Sciences)
Verdant Life Sciences Private Limited is the primary company behind Verdant Life Sciences. The board of Verdant Life Sciences Private Limited currently have 3 directors; the longest-serving is Sivarama Prasad Manne, appointed in 2009. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sivarama Prasad Manne DIN 00079145 | Director | 27 Apr 2009 | 17 yrs 6 mo | Verdant Life Sciences Private Limited |
| Ravindra Babu Gogineni DIN 00066738 | Director | 27 Apr 2009 | 17 yrs 6 mo | Verdant Life Sciences Private Limited |
| Dharma Pracharak Ramineni DIN 05125190 | Managing Director | 26 Apr 2013 | 13 yrs 6 mo | Verdant Life Sciences Private Limited |
People of Verdant Life Sciences
3 people are tracked at Verdant Life Sciences (3 in leadership); the tracked headcount is 139.
| Name | Role | Group |
|---|---|---|
V Satyanarayana Murthy | Co-Founder | Leadership |
U Amarnath | Co-Founder | Leadership |
| Co-Founder & Managing Director | Leadership |
Complete people profiles for Verdant Life Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Verdant Life Sciences
Figures of Verdant Life Sciences Private Limited, the primary company behind Verdant Life Sciences, for FY 2025. Revenue was ₹89.48 Cr (+6% year on year). Net profit was ₹67.2 Lakh (1% margin). EBITDA was ₹7.13 Cr (8% margin). Revenue has grown at a compounded annual rate of +4% over three years.
- ₹89.48 CrRevenue · FY 2025 · +6% YoY
- ₹67.2 LakhNet profit · 1% margin
- ₹7.13 CrEBITDA · 8% margin
- ₹20.35 CrPaid-up capital
- 139Employees (provident fund records)
- +4%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Verdant Life Sciences Private Limited are on its company page.
Detailed financial statements for Verdant Life Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Verdant Life Sciences
4 dated milestones of Verdant Life Sciences across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Verdant Life Sciences is founded.
- Funding First funding round of $438K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Angel Round, of $591K.
Competitors of Verdant Life Sciences
Verdant Life Sciences has 3 listed competitors in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed competitors of Verdant Life Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Verdant Life Sciences
The website of Verdant Life Sciences (verdantpharma.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▼ 5.8% vs previous month
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Verdant Life Sciences (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | USD 508.93 M | 4,050 | ||
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | USD 6.44 B | 19,801 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Verdant Life Sciences
Verdant Life Sciences was founded in 2008 and raised its 1st funding round 3 years after it was founded.
Verdant Life Sciences is headquartered in Visakhapatnam, India. It is registered at Visakhapatnam, Andhra Pradesh, India.
Verdant Life Sciences is a funded company, having raised a total of $1.43M across 3 funding rounds to date. The company's 1st funding round was a Angel Round of $437.75K, raised on Mar 2011.
Verdant Life Sciences has 139 employees.
The primary company behind Verdant Life Sciences, Verdant Life Sciences Private Limited, reported revenue of ₹89.48 Cr for FY 2025, up 6% year on year.
Verdant Life Sciences Is Engaged In The Production Of Active Pharmaceutical Ingredients And Intermediates. Based In India, The Company Serves Both Domestic And International Markets, Exporting To 18 Countries. Their State-of-the-art Manufacturing Facility Is Located In Visakhapatnam, Supported By Certifications Such As Who Gmp And Iso 9001:2015. Research And Development Efforts Are Directed Towards Non-infringing Apis. Products Are Supplied To Various Pharmaceutical Sectors With A Commitment To Quality.
Verdant Life Sciences's top competitors include Laurus Labs, Symbiotec and SeQuent.
Verdant Life Sciences offers Active Pharmaceutical Ingredients and Intermediates.
Verdant Life Sciences has 3 investors. Key investors include Venigalla Sambasiva Rao, Pathuri Nagabhushanan, and Manthena Raju.
The valuation of Verdant Life Sciences is $33.41M as of Apr 2012.
Verdant Life Sciences operates through Verdant Life Sciences Private Limited.
The legal entities of Verdant Life Sciences currently have 4 directors, including Sivarama Prasad Manne, Dharma Pracharak Ramineni, Ravindra Babu Gogineni and others.